All Stories

  1. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry

    Article • International Journal of Laboratory Hematology, May 2018, Wiley

    Anthony Dodds

  2. Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma

    Article • British Journal of Haematology, April 2017, Wiley

    Professor Jeff Szer, Anthony Dodds